Disrupting the Exosome Industry: Syed T. Husain and Yoram Drucker on Manufacturing at Scale
Following the announcement of Made Scientific’s partnership with NurExone Biologic for GMP manufacturing and aseptic fill-finish of NurExone’s exosomes, our Chairman and CEO, Syed T. Husain, sat down with NurExone’s Co-Founder and Chairman, Yoram Drucker, for an episode of the company’s podcast.
The conversation is highlighted below, with the full discussion available in the podcast episode.
🎧 Listen to the full episode on NurExone Biologic's podcast.
Highlights from the conversation
Partnership works as one team. Asked whether a cell-free product like exosomes is easier to make, Syed came back to preparation and partnership: "If there is a wall in between and things are getting thrown over, it won't be successful. If the partnership is embedded and everyone acts as one team toward a common goal, we will be successful." Yoram described the same thing from the other side of the table: "They're coming to the table as partners, sharing ideas, knowledge, and experience, a lot of things that we as a drug development company will need down the road."
Living cells need strong foundations and room to adapt. "There are fundamentals and strong foundations needed so that when we execute something, we do it the right way, with quality in mind and with patients in mind," Syed said. "But we need to be adaptable to what the cells bring us on a given day."
One platform, more than one product. Syed described a shared upstream process, built from the same master cell bank so consistency starts in the same place, and separate downstream steps for each use, down to the analytics and the batch record.
Boring manufacturing is the goal. "You often hear that when manufacturing is boring, things are going well," Syed said. "But boring can't be conflated with commoditization. At the end of the day, this is going into patients."
More in the full episode
The conversation also covers what exosomes are and how they're made, why batch-to-batch consistency is so hard to achieve, where the market for exosomes is heading, and Yoram's answer to whether exosomes are magic. Listen to the full episode.
Ready to discuss exosome manufacturing with our subject matter experts? Let's talk.
Podcast produced by NurExone Biologic and published on October 12, 2026. Quotes are lightly edited for length and clarity. Listen to the full episode on YouTube, and read the announcement of our partnership.
